Clinical Trial Update: Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

This entry reports on a Phase 2 clinical trial evaluating fludarabine phosphate, melphalan, and alemtuzumab followed by donor stem cell transplantation for rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Fludarabine phosphate (Fludarabine phosphate)
• Melphalan (Melphalan)

Snippet

Sponsor: Cancer Research UK | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN